Harrison E, Adjei A, Ameho C, Yamamoto S, Kono S
Department of Adult Health, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.
J Nutr Sci Vitaminol (Tokyo). 1998 Apr;44(2):257-68. doi: 10.3177/jnsv.44.257.
This study was designed to investigate the modulatory effect of dietary soybean protein on the skeleton of an ovariectomized rat model with postmenopausal osteoporosis. Thirty-two female Sprague-Dawley rats were weight matched and divided into the following four experimental groups: Soy group, ovariectomized and fed soy protein diet; Estrogen group, ovariectomized, fed casein diet and injected with estrogen; Casein group, ovariectomized and fed casein diet; and Sham group, sham-operated and fed casein diet. The diets and estrogen were started two weeks after surgery, and continued for four weeks. Rats in the Sham, Soy and Estrogen groups had significantly higher (p < 0.05) femur and tibia ash content than those in the Casein group. Accordingly, the calcium content of the tibia and femur were also significantly higher (p < 0.05) in the Soy, Estrogen and Sham groups as compared to the Casein group. Serum total and bone-type alkaline phosphatase levels were both significantly lower (p < 0.05) in the Estrogen and Sham groups in relation to the Soy and Casein groups. This study demonstrated that a 22% soybean protein diet could be just as effective as daily estrogen administration in suppressing bone loss due to ovariectomy. However, unlike estrogen, soy protein diet did not have any uterotrophic effect and did not decrease the markers of bone turnover measured, suggesting a possible difference in the mechanism of action.
本研究旨在探讨膳食大豆蛋白对绝经后骨质疏松卵巢切除大鼠模型骨骼的调节作用。32只体重匹配的雌性斯普拉格-道利大鼠被分为以下四个实验组:大豆组,卵巢切除并喂食大豆蛋白饮食;雌激素组,卵巢切除,喂食酪蛋白饮食并注射雌激素;酪蛋白组,卵巢切除并喂食酪蛋白饮食;假手术组,假手术并喂食酪蛋白饮食。术后两周开始给予饮食和雌激素,并持续四周。假手术组、大豆组和雌激素组大鼠的股骨和胫骨灰分含量显著高于酪蛋白组(p<0.05)。因此,与酪蛋白组相比,大豆组、雌激素组和假手术组大鼠胫骨和股骨的钙含量也显著更高(p<0.05)。与大豆组和酪蛋白组相比,雌激素组和假手术组血清总碱性磷酸酶和骨型碱性磷酸酶水平均显著降低(p<0.05)。本研究表明,22%的大豆蛋白饮食在抑制卵巢切除引起的骨质流失方面与每日给予雌激素同样有效。然而,与雌激素不同的是,大豆蛋白饮食没有任何子宫营养作用,也没有降低所测的骨转换标志物,提示其作用机制可能存在差异。